Why is Kamada Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.54%
- Poor long term growth as Net Sales has grown by an annual rate of 5.96% and Operating profit at 5.59% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 10.49%, it has a Expensive valuation with a 1.46 Price to Book Value
- Over the past year, while the stock has generated a return of 7.42%, its profits have risen by 41.3% ; the PEG ratio of the company is 0.3
3
Underperformed the market in the last 1 year
- The stock has generated a return of 7.42% in the last 1 year, much lower than market (Israel TA-100) returns of 48.91%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Kamada Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kamada Ltd.
7.42%
0.84
27.64%
Israel TA-100
48.91%
2.91
16.81%
Quality key factors
Factor
Value
Sales Growth (5y)
5.96%
EBIT Growth (5y)
5.59%
EBIT to Interest (avg)
22.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.64
Tax Ratio
7.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.84%
ROCE (avg)
9.54%
ROE (avg)
4.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.46
EV to EBIT
11.25
EV to EBITDA
7.17
EV to Capital Employed
1.61
EV to Sales
1.71
PEG Ratio
0.34
Dividend Yield
0.04%
ROCE (Latest)
14.28%
ROE (Latest)
10.49%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend






